Jonathan Violin

Jonathan Violin is a seasoned executive in the pharmaceutical and biotechnology sectors, currently serving as a Venture Partner at Fairmount Funds Management LLC since June 2023. Violin holds multiple board positions, including Member of the Board of Directors at Catabasis Pharmaceuticals, Inc., and Dianthus Therapeutics, Inc. Previously, Violin was the Founding CEO of Viridian Therapeutics, Inc., and Trevena, Inc., where significant contributions included leading New Drug Applications and enhancing investor relations strategies. Violin's experience spans various roles in corporate strategy, scientific affairs, and research, complemented by an academic background in biomedical sciences and health sector management from Duke University and UC San Diego.